About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,809 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,809 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2141-2160 of 10,809 trials

TerminatedTrial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete RemissionPatients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.NCT01656252·Worcester, Massachusetts and 4 others CompletedStudy of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast CancerThe primary objective is to determine the maximum tolerated dose/recommended phase II dose of the combination regimen of NK012 and carboplatin in patients with advanced solid…NCT01238952·Nashville, Tennessee CompletedIrinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineThe purpose of this phase II, randomized, open-label clinical trial is to study 2 schedules of single-agent Irinotecan in women with metastatic breast cancer who have experienced…NCT00072852·Mobile, Alabama and 65 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

RecruitingAxonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal IncontinenceSingle-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.NCT07499258·New York, New York and 3 others

Active not recruitingA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with…NCT04497844·Homewood, Alabama and 386 others

RecruitingAN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEMStudy Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that…NCT06378632·Fairhope, Alabama and 44 others

CompletedPCORnet Opioid Surveillance StudyThe overarching objective of this project is to demonstrate and assess the feasibility of using the Patient Centered Outcomes Research Network (PCORnet) Common Data Model for…NCT03743493·Irvine, California and 23 others

CompletedClinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390The purpose of this study is to test the safety and tolerability of eltrombopag when used to increase and maintain platelet count.NCT00996216·San Diego, California and 27 others

CompletedPK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic BladderAims of this study is to characterize the pharmacokinetic/pharmacodynamic profile and evaluate the safety, efficacy and tolerability, of tamsulosin hydrochloride as treatment in…NCT00340704·Birmingham, Alabama and 71 others

Active not recruitingTesting the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyThis phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with…NCT04248452·Anchorage, Alaska and 452 others

CompletedThe Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment IntensificationThis trial is conducted in Africa, Asia, Europe and North America.NCT01664247·Anaheim, California and 131 others

WithdrawnSafety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer PatientsThis study will evaluate the maximum tolerated dose and dose-limiting toxicities of vemurafenib and/or cobimetinib when used with onartuzumab in cancer patients.NCT01974258·Los Angeles, California and 5 others

Active not recruitingA Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and PK of a higher dose of ocrelizumab per intravenous (IV) infusion…NCT04548999·Homewood, Alabama and 146 others

CompletedImmunogenetics of Heparin-Induced Thrombocytopenia: Aim 2The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin.NCT02526485·Nashville, Tennessee

CompletedA Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar LinesFacial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with botulinum toxin.NCT05248893·Birmingham, Alabama and 42 others

RecruitingAvelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast CancerThis clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are…NCT04841148·Washington D.C., District of Columbia and 6 others

CompletedA Study of NGM621 in Participants With Geographic AtrophyThis is a multi-center evaluation of NGM621 in a randomized, double-masked, sham-controlled study in participants with Geographic Atrophy secondary to Age-related Macular…NCT04465955·Phoenix, Arizona and 64 others

RecruitingEvaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast MalignanciesFor patients with breast cancer, it's important to find any remaining cancer cells after they've had their main treatment.NCT07211178·Birmingham, Alabama and 15 others

CompletedStreamlining Trauma Research Evaluation With Advanced MeasurementThe STREAM Study is a prospective longitudinal observational outcomes study that will examine the reliability, validity and responsiveness of the PROMIS tools for clinical…NCT02079714·Birmingham, Alabama and 43 others

CompletedACT-293987 in Pulmonary Arterial HypertensionLong-term, single-arm, multicenter, open-label extension, Phase 3 study, to evaluate the safety and tolerability of ACT-293987 in patients with PAH who participated in the…NCT01112306·Mobile, Alabama and 156 others

PreviousPage 108 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville